Original document(9 pages)  中文版
    The present invention relates to an eudesmane type sesquiterpene derivative 1 beta-hydroxyilicic acid, namely 1 beta-hydroxy-5 alpha H-eudesmane-11 (13)-ethylene-12-acid, its medicineal salt or solvent compound and its medicine composition and medicinal application for preparing medicine capable of curing hepatitis B virus infective disease and resisting hepatitis B virus. Said invention also provides its chemical structure formula.
Application Number
申请号		 200610053625 Application Date
申请日		 2006.09.27
Title 名称 Pharmaceutical use of 1 beta-hydroxy ilexolic acid for inhibiting hepatitis virus
Publication Number
公开号		 1935131 Publication Date
公开日		 2007.03.28
Approval Pub. Date Granted Pub. Date
International Classification 分类号 A61K31/192;A61P1/16;A61P31/12;C07C59/46
Applicant(s) Name
申请人		 Wenzhou Medical College
Address 地址
Inventor(s) Name 发明人
Attorney & Agent 代理人
More information 更  多  信  息


 Related patents information
Ramification of pentacycle triterpene, preparation method and application
Eremophil dilactone with tumour cell growth inhibiting activity and its use
Eremophil dilactone natural product with tumour cell growth inhibiting activity
New compound and organic light emitting device using the same(4)
Analog of mono carbonyl structure of curcumin, and usage
Preparing compound of phenols difluoro heptane category, and oxidation resistant applcation
New compound and organic light emitting device using the same(9)
New compound and organic light emitting device using the same(8)
New compound and organic light emitting device using the same(2)
Eremophil-2-internal-ester diploymer having function of inhibiting tumor cell growth activity and use thereof
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.